Conference Reports for NATAP

13th International Workshop on Clinical Pharmacology of HIV Therapy Barcelona, Spain April 16-18, 2012 Back

Antiviral activity, exposure-response, and resistance analyses of monotherapy with the novel HIV nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 in antiretroviral treatment-experienced subjects       Antiviral activity, exposure-response, and resistance analyses of monotherapy with the novel HIV nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 in antiretroviral treatment-experienced subjects